Global Herpes simplex Partnering 2010 to 2017

Publisher Name :
Date: 01-Nov-2017
No. of pages: 150
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

The Global Herpes simplex Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

• Trends in partnering deals

• Top deals by value

• Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Key benefits

Global Herpes simplex Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits:

• In-depth understanding of deal trends since 2010

• Access to headline, upfront, milestone and royalty data

• Comprehensive access to multiple deals entered into by the world's biopharma companies since 2010

• Insight into key deal terms included in contracts, where disclosed

• Understand the key deal terms companies have agreed in deals

• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Global Herpes simplex Partnering 2010 to 2017

Table of Contents

Executive Summary

Chapter 1 - Therapypartnering trends in numbers

Partnering in numbers - by year
Partnering in numbers - most active
Partnering in numbers - by industry sector
Partnering in numbers - by deal type
Partnering in numbers - by technology type
Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

Partnering deals directory - by company A-Z
Partnering deals directory - by deal value
Partnering deals directory - by industry sector
Partnering deals directory - by deal type
Partnering deals directory - by stage of development
Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

Chapter 5 - M&A in numbers

M&A in numbers - by year

Chapter 6 - M&A deals directory

M&A deals directory - by company A-Z
M&A deals directory - by deal value

Chapter 7 - Financing in numbers

Financing in numbers - by year
Financing in numbers - by financing type

Chapter 8 - Financing deals directory

Financing deals directory - by company A-Z
Financing deals directory - by deal value
Financing deals directory - by financing type

About Wildwood Ventures

Current Partnering
Current Agreements
Recent titles from CurrentPartnering

List of Figures

Figure 1: Partnering frequency by year
Figure 2: Partnering most active
Figure 3: Partnering by industry sector
Figure 4: Partnering by deal type
Figure 5: Partnering by technology area
Figure 6: Partnering by stage of development
Figure 7: M&A frequency by year
Figure 8: Financing frequency by year
Figure 9: Financing by type
  • Global and United States Neisseria meningitidis Infections Drug Market Research by Company, Type & Application 2013-2025
    Published: 13-Jul-2018        Price: US 2000 Onwards        Pages: 128
    Summary Market Segment as follows: By Type - MGBBP-3 - NCL-195 - TP-10 - Others By Application - Hospital - Clinic - Others By Company - Beijing Minhai Biotechnology Co Ltd - Biological E Ltd - China National Pharmaceutical Group Corp - GlaxoSmithKline Plc - Griffith University - ImmunoBiology Ltd - JN-International Medical Corp - MGB Biopharma Ltd - Panacea......
  • Global and United States Ampicillin Market Research by Company, Type & Application 2013-2025
    Published: 08-Jul-2018        Price: US 2000 Onwards        Pages: 121
    Summary Market Segment as follows: By Type - Ampicillin Capsules - Ampicillin Sodium - Ampicillin Granules By Application - Adults - Kids By Company - DSM - ACS Dobfar - Kopran - Antibioticos - United Laboratories - Shandong Lukang Pharmaceutical - CSPC Pharmaceutical - North China Pharmaceutical - Huaxing Pharmaceutical The main co......
  • Global and United States Polymixin Market Research by Company, Type & Application 2013-2025
    Published: 04-Jul-2018        Price: US 2000 Onwards        Pages: 118
    Summary Market Segment as follows: By Type - Oral Usage - Injection By Application - Pigs - Chickens - Cows By Company - Apeloa - Shengxue Dacheng - Livzon Group - LKPC - Xellia - BIOK - Vetbiochem - Qianjiang Biochemical - VEGA - Huazhong Pharmaceutical The main contents of the report including: Section 1: Product def......
  • Global Polymixin Market Professional Survey Report 2018
    Published: 02-Jul-2018        Price: US 3500 Onwards        Pages: 111
    This report studies the global Polymixin market status and forecast, categorizes the global Polymixin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Polymyxins are antibiotics, with a general structure consisting of a cyclic peptide with a long hydrophobic tail. They disrupt ......
  • 2013-2023 Global Cephalosporin Industry Report
    Published: 01-Jul-2018        Price: US 4000 Onwards        Pages: 141
    The global market size of Cephalosporin is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss follow......
  • Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2018
    Published: 29-Jun-2018        Price: US 2000 Onwards        Pages: 81
    Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2018, provides an overview of the Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) pipeline landscape. Avian influenza A (H7N9) is a subtype of influenza viruses. This infection is seen both in humans and birds. Infecti......
  • Hepatitis Drug Development Pipeline Review, 2018
    Published: 29-Jun-2018        Price: US 3995 Onwards        Pages: 133
    Hepatitis Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for hepatitis infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hepatitis A, hepatitis B, hepatitis D and hepatitis E, and features dormant and discontinued products. Hepatitis refers to inflammation of the liver and is most commonly caused by viral i......
  • Herpes Simplex -Epidemiology Forecast to 2027
    Published: 28-Jun-2018        Price: US 3250 Onwards        Pages: 70
    DelveInsight's ‘Herpes Simplex Virus (HSV) Infections- Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of HSV infections in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. Geography Covered - The United States - EU5 (Germany, France, Italy, Spain and the United Kingdom) - Japan Study Period: 2016-2027 HSV infections Epidemiolog......
  • 2015-2023 World Cefazolin Sodium Market Research Report by Product Type, End-User (Application) and Regions (Countries)
    Published: 16-Jun-2018        Price: US 2800 Onwards        Pages: 104
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc) - Middle East & Afri......
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs